BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1284 related articles for article (PubMed ID: 16904809)

  • 1. Enzyme-kinetic investigation of different sarin analogues reacting with human acetylcholinesterase and butyrylcholinesterase.
    Bartling A; Worek F; Szinicz L; Thiermann H
    Toxicology; 2007 Apr; 233(1-3):166-72. PubMed ID: 16904809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of pentylsarin analogues with human acetylcholinesterase: a kinetic study.
    Worek F; Herkert NM; Koller M; Aurbek N; Thiermann H
    Toxicol Lett; 2009 Jun; 187(2):119-23. PubMed ID: 19429253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic analysis of interactions of different sarin and tabun analogues with human acetylcholinesterase and oximes: is there a structure-activity relationship?
    Aurbek N; Herkert NM; Koller M; Thiermann H; Worek F
    Chem Biol Interact; 2010 Sep; 187(1-3):215-9. PubMed ID: 20105433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suitability of human butyrylcholinesterase as therapeutic marker and pseudo catalytic scavenger in organophosphate poisoning: a kinetic analysis.
    Aurbek N; Thiermann H; Eyer F; Eyer P; Worek F
    Toxicology; 2009 May; 259(3):133-9. PubMed ID: 19428953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic analysis of reactivation and aging of human acetylcholinesterase inhibited by different phosphoramidates.
    Worek F; Aurbek N; Koller M; Becker C; Eyer P; Thiermann H
    Biochem Pharmacol; 2007 Jun; 73(11):1807-17. PubMed ID: 17382909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds with human and pig acetylcholinesterase.
    Aurbek N; Thiermann H; Szinicz L; Eyer P; Worek F
    Toxicology; 2006 Jul; 224(1-2):91-9. PubMed ID: 16720069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes.
    Worek F; Thiermann H; Szinicz L; Eyer P
    Biochem Pharmacol; 2004 Dec; 68(11):2237-48. PubMed ID: 15498514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of reversible ligands on oxime-induced reactivation of sarin- and cyclosarin-inhibited human acetylcholinesterase.
    Scheffel C; Thiermann H; Worek F
    Toxicol Lett; 2015 Feb; 232(3):557-65. PubMed ID: 25522658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of oxime-induced reactivation of erythrocyte and muscle AChE from different animal species following inhibition by sarin or paraoxon.
    Herkert NM; Aurbek N; Eyer P; Thiermann H; Worek F
    Toxicol Lett; 2010 May; 194(3):94-101. PubMed ID: 20156534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactivation kinetics of a homologous series of bispyridinium bis-oximes with nerve agent-inhibited human acetylcholinesterase.
    Worek F; von der Wellen J; Musilek K; Kuca K; Thiermann H
    Arch Toxicol; 2012 Sep; 86(9):1379-86. PubMed ID: 22437842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism for potent reactivation ability of H oximes analyzed by reactivation kinetic studies with cholinesterases from different species.
    Luo C; Chambers C; Yang Y; Saxena A
    Chem Biol Interact; 2010 Sep; 187(1-3):185-90. PubMed ID: 20096273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural requirements for effective oximes--evaluation of kinetic in vitro data with phosphylated human AChE and structurally different oximes.
    Worek F; Wille T; Koller M; Thiermann H
    Chem Biol Interact; 2013 Mar; 203(1):125-8. PubMed ID: 22827894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A common mechanism for resistance to oxime reactivation of acetylcholinesterase inhibited by organophosphorus compounds.
    Maxwell DM; Brecht KM; Sweeney RE
    Chem Biol Interact; 2013 Mar; 203(1):72-6. PubMed ID: 22982773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivation and aging kinetics of human acetylcholinesterase inhibited by organophosphonylcholines.
    Worek F; Thiermann H; Szinicz L
    Arch Toxicol; 2004 Apr; 78(4):212-7. PubMed ID: 14647978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity analysis of aging and reactivation of human butyrylcholinesterase inhibited by analogues of tabun.
    Carletti E; Aurbek N; Gillon E; Loiodice M; Nicolet Y; Fontecilla-Camps JC; Masson P; Thiermann H; Nachon F; Worek F
    Biochem J; 2009 Jun; 421(1):97-106. PubMed ID: 19368529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of nine oximes on in vivo reactivation of blood, brain, and tissue cholinesterase activity inhibited by organophosphorus nerve agents at lethal dose.
    Shih TM; Skovira JW; O'Donnell JC; McDonough JH
    Toxicol Mech Methods; 2009 Sep; 19(6-7):386-400. PubMed ID: 19778239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between acetylcholinesterase, toxic organophosphorus compounds and a short series of structurally related non-oxime reactivators: Analysis of reactivation and inhibition kinetics in vitro.
    Horn G; de Koning MC; van Grol M; Thiermann H; Worek F
    Toxicol Lett; 2018 Dec; 299():218-225. PubMed ID: 30312685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of two new oximes in reactivate human acetylcholinesterase and butyrylcholinesterase inhibited by organophosphate compounds: an in vitro study.
    Costa MD; Freitas ML; Soares FA; Carratu VS; Brandão R
    Toxicol In Vitro; 2011 Dec; 25(8):2120-3. PubMed ID: 21983245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonquaternary reactivators for organophosphate-inhibited cholinesterases.
    Kalisiak J; Ralph EC; Cashman JR
    J Med Chem; 2012 Jan; 55(1):465-74. PubMed ID: 22206546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetic prerequisites of oximes as effective reactivators of organophosphate-inhibited acetylcholinesterase: a theoretical approach.
    Worek F; Aurbek N; Wille T; Eyer P; Thiermann H
    J Enzyme Inhib Med Chem; 2011 Jun; 26(3):303-8. PubMed ID: 20807085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 65.